Market Research Logo

ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an u


Section 1 - About the Company
ALK-Abello AS - Key Facts
ALK-Abello AS - Key Employees
ALK-Abello AS - Key Employee Biographies
ALK-Abello AS - Major Products and Services
ALK-Abello AS - History
ALK-Abello AS - Company Statement
ALK-Abello AS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
ALK-Abello AS - Business Description
Product Category: Other Products and Services
Overview
Performance
Product Category: SCIT/SLIT-drops
Overview
Performance
Product Category: SLIT Tablets
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Performance
R&D Overview
ALK-Abello AS - Corporate Strategy
ALK-Abello AS - SWOT Analysis
SWOT Analysis - Overview
ALK-Abello AS - Strengths
ALK-Abello AS - Weaknesses
ALK-Abello AS - Opportunities
ALK-Abello AS - Threats
ALK-Abello AS - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ALK-Abello AS, Recent Deals Summary
Section 5 - Company’s Recent Developments
Feb 07, 2019: ALK releases its annual report 2018
Jan 15, 2019: ALK's board of directors to nominate Vincent Warnery as new member of the Board
Jan 11, 2019: ALK appoints new head of product supply
Nov 09, 2018: ALK Abello: Nine-month interim report 2018
Oct 17, 2018: ALK s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet
Oct 17, 2018: New Treatment for House Dust Mite (HDM) Induced Allergic Rhinitis Now Available in US
Sep 17, 2018: Nima partners with global allergy leader ALK for European distribution
Aug 15, 2018: ALK-Abello: Six-month interim report (Q2) 2018
May 04, 2018: ALK Releases Three-month interim report (Q1) 2018
May 04, 2018: ALK Abello: Three-month interim report (Q1) 2018
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
ALK-Abello AS, Key Facts
ALK-Abello AS, Key Employees
ALK-Abello AS, Key Employee Biographies
ALK-Abello AS, Major Products and Services
ALK-Abello AS, History
ALK-Abello AS, Subsidiaries
ALK-Abello AS, Key Competitors
ALK-Abello AS, Ratios based on current share price
ALK-Abello AS, Annual Ratios
ALK-Abello AS, Annual Ratios (Cont...1)
ALK-Abello AS, Annual Ratios (Cont...2)
ALK-Abello AS, Interim Ratios
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ALK-Abello AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
ALK-Abello AS, Performance Chart (2014 - 2018)
ALK-Abello AS, Ratio Charts
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report